Nuffield Health to enhance disease detection by cutting-edge imaging technology investment in PENTAX
PENTAX Medical awarded significant contract for high definition HD+ endoscopes by UK’s largest health charity
PENTAX Medical has been providing some Nuffield hospitals with its extensive range of cutting-edge endoscopy equipment for a variety of procedures for over 15 years and is world-renowned for the quality, reliability, innovation and simplicity of its products. The new national contract offers exceptional value for money within flexible financial solutions, enabling increased investment by Nuffield Health in PENTAX Medical’s, high-definition endoscopes and associated technology. This will be backed up by PENTAX’s best in class service, support and training to wholly ensure that Nuffield’s patients are provided with the best possible care and clinical outcomes.
Use of PENTAX Medical’s revolutionary ‘i-scan’ imaging technology alongside the HD+ endoscope range will further improve imagery of tissues, such as those lining the stomach, intestines and bladder. Obtaining the best quality image possible inside a patient means disease can be detected earlier, before it reaches a serious stage, and treatment can begin without delay to improve a patient’s chance of recovery.
For example, colorectal cancer is one of the most common cancers worldwide, early detection of cancer, as well as detection and removal of polyps, using colonoscopy is vital to decrease disease mortality. Use of PENTAX HD+ colonoscopes in conjunction with i-scan has been shown to provide an enhanced resolution and visualisation of polyps1,2. This leads to a significantly higher detection rate of polyps, specifically potentially pre-cancerous tissues or adenomas, compared to standard video endoscopy during bowel cancer screening programmes.
Many leading doctors already trust PENTAX’s endoscopes to improve the detection and diagnosis of tissue abnormalities1,2,3. According to David Moore, Managing Director, PENTAX UK Ltd. “By choosing the most technologically advanced endoscopy products on the market that offer such exceptionally high image resolution, compared to standard endoscopes, Nuffield Health will be able to offer its patients significantly higher detection rates for cancers and other diseases, as well as enabling faster treatment turnaround times.”
David Wylde, Regional Director – Hospitals, Nuffield Health commented, “The new national contract with PENTAX Medical will ensure we can diagnose our patients using the most advanced endoscopy technology available within Nuffield Hospitals. We take pride in delivering an excellent service and being able to use the latest, cutting-edge technology means that we can deliver truly high class healthcare to our patients.
We are also extremely impressed with the expertise and knowledge held within the PENTAX Medical team who are evidently dedicated to delivering quality and excellence in both technology and after-sales care. The introduction of PENTAX technology supports our upgrade of Endoscopy facilities to meet the accreditation of the Joint Advisory Group on GI Endoscopy (JAG) to ensure that we continue to be a provider of services of the highest quality.”
Banks M.R. et al. (2011). Comparison of PENTAX Hi Line and Olympus Lucera Colonoscopes for polyp detection in the UK bowel cancer screening programme. World Journal of Gastroenterology, 17 (38): 4308-4313.
Hoffman A. et al. (2010). High definition colonoscopy combined with i-Scan is superior in the detection of colorectal neoplasias compared with standard video colonoscopy:
Endoscopy and Early Neoplasia: Embracing the Future. Gastroenterology Today (September 2012).
For more information please visit: www.pentaxmedical.com